Phase I trial of oral S-1 combined with hepatic arterial infusion of gemcitabine in unresectable biliary tract cancer

被引：0
|
作者：
Hirotoshi Ishiwatari
Tsuyoshi Hayashi
Makoto Yoshida
Michihiro Ono
Tsutomu Sato
Koji Miyanishi
Yasushi Sato
Rishu Takimoto
Masayoshi Kobune
Junji Kato
机构：
[1] Sapporo Medical University School of Medicine,Department of Medical Oncology and Hematology
来源：
Cancer Chemotherapy and Pharmacology | 2015年 / 75卷
关键词：
Biliary tract cancer; Hepatic arterial infusion; Chemotherapy; S-1; Gemcitabine; Neutropenia;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
下载
收藏
页码：805 / 812
页数：7
相关论文
共 50 条
  • [41] Hepatic Arterial Infusion Oxaliplatin Plus Oral S-1 Chemotherapy in Gastric Cancer with Unresectable Liver Metastases: A Case Series and Literature Review
    Wang, Kangxin
    Zhang, Xuebin
    Wei, Jia
    Xu, Yiwen
    Liu, Qin
    Xie, Jiaqi
    Yuan, Lihua
    Sun, Zhichen
    Tan, Siyi
    Zhang, Lianru
    Liu, Baorui
    Yang, Yang
    CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 863 - 870
  • [42] Toripalimab combined with gemcitabine and S-1 in the first-line treatment of advanced biliary tract cancer.
    Li, Wei
    Wang, Yueqi
    Yu, Yiyi
    Li, Qian
    Wang, Yan
    Zhang, Chenlu
    Xu, Xiaojing
    Guo, Xi
    Cui, Yuehong
    Hao, Qing
    Huang, Lujia
    Liu, Houbao
    Liu, Tianshu
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [43] A randomized phase II study of gemcitabine and S-1 combination therapy versus gemcitabine monotherapy for advanced biliary tract cancer
    Takashi Sasaki
    Hiroyuki Isayama
    Yousuke Nakai
    Yukiko Ito
    Ichiro Yasuda
    Nobuo Toda
    Hirofumi Kogure
    Keiji Hanada
    Hiroyuki Maguchi
    Naoki Sasahira
    Hideki Kamada
    Tsuyoshi Mukai
    Yoshihiro Okabe
    Osamu Hasebe
    Iruru Maetani
    Kazuhiko Koike
    Cancer Chemotherapy and Pharmacology, 2013, 71 : 973 - 979
  • [44] A randomized phase II study of gemcitabine and S-1 combination therapy versus gemcitabine monotherapy for advanced biliary tract cancer
    Sasaki, Takashi
    Isayama, Hiroyuki
    Nakai, Yousuke
    Ito, Yukiko
    Yasuda, Ichiro
    Toda, Nobuo
    Kogure, Hirofumi
    Hanada, Keiji
    Maguchi, Hiroyuki
    Sasahira, Naoki
    Kamada, Hideki
    Mukai, Tsuyoshi
    Okabe, Yoshihiro
    Hasebe, Osamu
    Maetani, Iruru
    Koike, Kazuhiko
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 71 (04) : 973 - 979
  • [45] Phase I study of nivolumab or nivolumab/cisplatin/gemcitabine to treat unresectable/recurrent biliary tract cancer
    Morizane, Chigusa
    Ikeda, Masafumi
    Ueno, Makoto
    Kobayashi, Satoshi
    Ohno, Izumi
    Kondo, Shunsuke
    Okano, Naohiro
    Kimura, Keisuke
    Asada, Suguru
    Namba, Yoshinobu
    Okusaka, Takuji
    Furuse, Junji
    ANNALS OF ONCOLOGY, 2019, 30
  • [46] A phase I study of gemcitabine (GEM) with concomitant radiotherapy in the treatment of unresectable, localized biliary tract cancer
    Gallardo, Jorge
    Rubio, B.
    Barrajas, O.
    Ayala, V.
    ANNALS OF ONCOLOGY, 2004, 15 : 245 - 246
  • [47] A phase I study of gemcitabine (GEM) with concomitant radiotherapy in the treatment of unresectable, localized biliary tract cancer
    Harbst, H
    Gallardo, J
    Rubio, B
    INTERNATIONAL JOURNAL OF CANCER, 2002, : 234 - 234
  • [48] A phase II trial of S-1 and cisplatin in patients with metastatic or relapsed biliary tract cancer
    Kim, Y. J.
    Im, S. -A.
    Kim, H. G.
    Oh, S. Y.
    Lee, K. W.
    Choi, I. S.
    Oh, D. Y.
    Lee, S. H.
    Kim, J. H.
    Kim, D. W.
    Kim, T. Y.
    Kim, S. W.
    Heo, D. S.
    Yoon, Y. B.
    Bang, Y. J.
    ANNALS OF ONCOLOGY, 2008, 19 (01) : 99 - 103
  • [49] Randomized phase II study of gemcitabine plus S-1 versus S-1 in advanced biliary tract cancer: A Japan Clinical Oncology Group trial (JCOG 0805)
    Morizane, Chigusa
    Okusaka, Takuji
    Mizusawa, Junki
    Takashima, Atsuo
    Ueno, Makoto
    Ikeda, Masafumi
    Hamamoto, Yasuo
    Ishii, Hiroshi
    Boku, Narikazu
    Furuse, Junji
    CANCER SCIENCE, 2013, 104 (09): : 1211 - 1216
  • [50] Multicenter, phase II study of gemcitabine and S-1 combination chemotherapy in patients with advanced biliary tract cancer
    Takashi Sasaki
    Hiroyuki Isayama
    Yousuke Nakai
    Yukiko Ito
    Hirofumi Kogure
    Osamu Togawa
    Nobuo Toda
    Ichiro Yasuda
    Osamu Hasebe
    Iruru Maetani
    Naoki Sasahira
    Kenji Hirano
    Takeshi Tsujino
    Minoru Tada
    Masao Omata
    Cancer Chemotherapy and Pharmacology, 2010, 65 : 1101 - 1107
12345